Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)Simon J Crabb, Sarah Danson, James W F Catto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2020
Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)Simon J Crabb, Gareth Griffiths, Ellice Marwood, et al.The Journal of Antimicrobial Chemotherapy|August 27, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled studySaye H Khoo, Richard Fitzgerald, Thomas Fletcher, et al.Pageof 1